“…Finally, a recent review of the literature using the MeSH term COVID associated coagulopathy reveals that this term was a standard descriptor for the singular observation of these patients to develop early clots that required delicate and closely monitored anti-coagulation [ 8 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ].…”